NCT00339001

Erythropoietin and Early Iron Supplement and Retinopathy of Prematurity

The Possible Influence of Erythropoietin and Early Iron Supplements on the Prevalence and Severity of Retinopathy of Prematurity and Other Short Term Outcome of Prematurity

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 400 (planned)
• Sponsor: Sheba Medical Center · Other Government
• Sex: All
• Age: 2 Weeks – 3 Months
• Healthy volunteers: Not accepted

Summary

To evaluate the possibility that erythropoietin with early iron supplementation may induce retinopathy of prematurity or worsen this disease. In addition risk factors for the development of ROP will be checked.

Conditions

• Retinopathy of Prematurity

Interventions

Type	Name	Description
DRUG	erythropoietin and early iron supplements

Timeline

• Start date: 2006-04-01
• Completion: 2006-12-01
• First posted: 2006-06-20
• Last updated: 2006-06-20

Locations

1 site across 1 country: Israel